Clinical Trials Browser

Unknown × Interventional × Sirolimus × Clear all

NCT04888741 2023-09-28

MoTD

Phase 2 Unknown

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT03217669 2023-05-03

Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05508620 2022-08-23

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Malignant Solid Tumors

NCT03805399 2022-08-10

FUTURE

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT05125523 2022-01-25

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumors

NCT03781050 2019-01-23

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Phase 4 Unknown

Hereditary Sensory and Autonomic Neuropathies, Peutz-Jeghers Syndrome

NCT03662412 2018-09-07

Study of Sirolimus in Patients With Advanced Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT03500367 2018-04-18

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

Phase 4 Unknown

Leiomyoma

NCT00490789 2008-04-30

TESSTAL

Phase 2 Unknown

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00554125 2007-11-06

Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular